Clinical Immunization Safety Assessment IDIQ

April 14, 2023. Consolidated list of questions received and Govrnment responses added. Amendment 01 dated April 7, 2023 is added to change the Inquiry response date, change the project Contracting Officer, add a clause incorporated by reference, and amend the Sample Task Order SOW and Evaluation Criteria. See attached SF30, Amendment #1 of Sol;icitation 75D301 23R The purpose of this CISA Project indefinite delivery, indefinite quantity (IDIQ) contract is to provide the CDC’s Division of Health Care Quality Promotion (DHQP), Immunization Safety Office (ISO) with an “as needed” mechanism to obtain required services, including an ongoing service for expert clinical consultation, through the issuance of individual Task Orders. These Task Orders would support vaccine safety monitoring and evaluation that meet public health needs for CDC. CDC may make multiple awards to contract with certain organizations (e.g., academic centers or health plans) in the United States. The CISA Project will be a resource to address clinical vaccine safety issues and provide a public health service to the nation. The project will also contribute to or conduct studies to answer questions about the safety of vaccines recommended for use in the United States and how to prevent AEFI. Results from such studies shall provide evidence to better inform vaccination practices.